Emory University School of Medicine has just been granted a $6.1M grant from the NIH to conduct research on re-programming cells taken from bone marrow or peripheral blood of patients with diabetes to treat neurovascular complications such as diabetic neuropathy. The research team will include investigators from Emory, Georgia Tech, University of Alabama, and University of California at San Diego. READ MORE
Source: Woodruff Health Sciences Center (Emory)